SCHEMBL7016808

SCHEMBL7016808

COC(=O)C1CN(C(=O)Oc2cccc3c2Cc2ccccc2-3)CCO1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PDK1 Q15118 1/20 0.43
▸ TP53 P04637 1/20 0.40
▸ POLB P06746 1/20 0.38
▸ RAB9A P51151 4/20 0.37
▸ NPC1 O15118 2/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ TSHR P16473 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ MEN1 O00255 3/20 0.34
▸ KMT2A Q03164 3/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ BCHE P06276 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ CD274 Q9NZQ7 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7022249 0.89 TP53 (0.42) PDK1TP53POLBRAB9ANPC1
SCHEMBL7016802 0.88 PDK1 (0.43) PDK1TP53POLBRAB9ANPC1
SCHEMBL7018475 0.82 TP53 (0.41) PDK1TP53POLBRAB9ANPC1
SCHEMBL7022253 0.76 TP53 (0.42) PDK1TP53POLBRAB9ANPC1
SCHEMBL9524815 0.70 MEN1 (0.57) PDK1RAB9ANPC1SMN1; SMN2MEN1
SCHEMBL7018480 0.69 TP53 (0.41) PDK1TP53POLBSMN1; SMN2BCHE
SCHEMBL2131214 0.69 RAB9A (0.55) TP53RAB9ANPC1SMN1; SMN2TSHR
SCHEMBL8840922 0.68 RAB9A (0.54) RAB9ANPC1SMN1; SMN2KDM4EMAPK1
SCHEMBL31245777 0.68 ALDH1A1 (0.51) RAB9ANPC1SMN1; SMN2KDM4EMAPK1
SCHEMBL20917777 0.67 RAB9A (0.49) RAB9ANPC1SMN1; SMN2KDM4EMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1206265-B1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2003-11-12 — — EP disclosed
US-6498165-B1 PYRIMIDINE COMPOUNDS; PROPHYLAXIS AND TREATMENT OF SUCH AS IMMUNE DISEASES, HYPERPROLIFERATIVE DISORDERS, CANCER, ANGIOGENSIS, ATHEROSCELEROSIS, GRAFT REJECTION, RHEUMATOID ARTHRITIS, PSORIASIS MERCK & CO., INC. 2002-12-24 — — US disclosed
EP-1194152-A4 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2002-11-06 — — EP disclosed
EP-1206265-A4 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2002-08-07 — — EP disclosed
EP-1206265-A1 SRC KINASE INHIBITOR COMPOUNDS Merck & Co., Inc. (US) 2002-05-22 — — EP disclosed
EP-1194152-A1 SRC KINASE INHIBITOR COMPOUNDS Merck & Co., Inc. (US) 2002-04-10 — — EP disclosed
US-6316444-B1 SRC kinase inhibitor compounds MERCK & CO., INC. 2001-11-13 — — US disclosed
WO-2001000213-A1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO., INC. (US) 2001-01-04 — — WO disclosed
WO-2001000214-A1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO., INC. (US) 2001-01-04 — — WO disclosed
Send feedback